MedImmune UK, Ltd.

Form 483 issued June 8, 2018 · Liverpool, United Kingdom

Inspection
May 29 – Jun 8, 2018
Observations
6
Pages
4
FEI number
3004066112

In short: On June 8, 2018, FDA issued a Form 483 with 6 observations to MedImmune UK, Ltd. in Liverpool, United Kingdom (FEI 3004066112) after an inspection that ran May 29 – Jun 8, 2018. The investigator was Omotunde O. Osunsanmi. Most observations concern production and materials; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

Production and materials account for 4 of 6 observations.

Production3
Materials1
Laboratory controls1
Other1

Most cited: 21 CFR 211.100 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Observation 1: scanned text, readable in the full document.

  2. 02

    SOP 100296 Version 7.0, titled: Deviation Procedure that includes procedure for corrective and preventive actions (CAPA)…

  3. 03

    During the observation of the sterility testing of…

  4. 04

    Critical] © and equipment alarms that occurred during the manufacture of 4) are not trended for…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at MedImmune UK, Ltd.?

FDA listed 6 observations on this Form 483, mostly about production, materials and laboratory controls. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected MedImmune UK, Ltd.?

Omotunde O. Osunsanmi is named on this Form 483, for the inspection of May 29 – Jun 8, 2018. Each investigator has a profile showing what they cite most.

When was MedImmune UK, Ltd. inspected by FDA?

The inspection ran May 29 – Jun 8, 2018, and the Form 483 is dated June 8, 2018.

How do I get the full Form 483 for MedImmune UK, Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free